Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

ARDX Ardelyx Inc

Price (delayed)

$3.6

Market cap

$861.32M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.22

Enterprise value

$985.62M

Ardelyx is focused on discovering, developing, and commercializing innovative first-in-class medicines to enhance the lives of patients with kidney and cardiorenal diseases. Ardelyx is advancing tenapanor, a novel product candidate ...

Highlights
The company's revenue has surged by 127% YoY and by 8% QoQ
The company's gross profit has surged by 125% YoY and by 8% QoQ
The net income has decreased by 37% from the previous quarter but it has increased by 18% YoY
The EPS has declined by 29% since the previous quarter but it has increased by 24% year-on-year
Ardelyx's debt has increased by 48% YoY
Ardelyx's equity has decreased by 16% QoQ and by 3.5% YoY

Key stats

What are the main financial stats of ARDX
Market
Shares outstanding
239.26M
Market cap
$861.32M
Enterprise value
$985.62M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.89
Price to sales (P/S)
2.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.72
Earnings
Revenue
$361.71M
Gross profit
$305.98M
Operating income
-$39.62M
Net income
-$53.76M
EBIT
-$37.92M
EBITDA
-$31.7M
Free cash flow
-$48.73M
Per share
EPS
-$0.22
EPS diluted
-$0.22
Free cash flow per share
-$0.2
Book value per share
$0.61
Revenue per share
$1.52
TBVPS
$1.72
Balance sheet
Total assets
$410.19M
Total liabilities
$264.52M
Debt
$155.11M
Equity
$145.68M
Working capital
$236.85M
Liquidity
Debt to equity
1.06
Current ratio
4.12
Quick ratio
3.43
Net debt/EBITDA
-3.92
Margins
EBITDA margin
-8.8%
Gross margin
84.6%
Net margin
-14.9%
Operating margin
-11%
Efficiency
Return on assets
-13.8%
Return on equity
-34.4%
Return on invested capital
-9.5%
Return on capital employed
-11.3%
Return on sales
-10.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARDX stock price

How has the Ardelyx stock price performed over time
Intraday
-3.23%
1 week
-2.17%
1 month
6.19%
1 year
-44.53%
YTD
-28.99%
QTD
-26.68%

Financial performance

How have Ardelyx's revenue and profit performed over time
Revenue
$361.71M
Gross profit
$305.98M
Operating income
-$39.62M
Net income
-$53.76M
Gross margin
84.6%
Net margin
-14.9%

ARDX financials

The company's revenue has surged by 127% YoY and by 8% QoQ
The company's gross profit has surged by 125% YoY and by 8% QoQ
ARDX's operating margin has surged by 72% year-on-year but it is down by 31% since the previous quarter
Ardelyx's net margin has surged by 64% YoY but it has decreased by 27% QoQ

Price vs fundamentals

How does ARDX's price correlate with its fundamentals

ARDX Price vs fundamentals

ARDX Earnings waterfall

ARDX Price vs fair value

Growth

What is Ardelyx's growth rate over time

ARDX growth chart

Valuation

What is Ardelyx stock price valuation
P/E
N/A
P/B
5.89
P/S
2.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.72

Valuation vs average

Price to earnings (P/E)

The EPS has declined by 29% since the previous quarter but it has increased by 24% year-on-year

Price to book (P/B)

ARDX's P/B is 37% below its last 4 quarters average of 9.3 but 3.3% above its 5-year quarterly average of 5.7
Ardelyx's equity has decreased by 16% QoQ and by 3.5% YoY

Price to sales (P/S)

The company's revenue has surged by 127% YoY and by 8% QoQ
The price to sales (P/S) is 91% lower than the 5-year quarterly average of 25.0 and 56% lower than the last 4 quarters average of 5.4

Efficiency

How efficient is Ardelyx business performance
The return on sales has surged by 72% year-on-year but it has declined by 35% since the previous quarter
The company's return on invested capital has surged by 58% YoY but it fell by 38% QoQ
Ardelyx's ROA has increased by 40% YoY but it has decreased by 31% from the previous quarter
Ardelyx's ROE has decreased by 38% from the previous quarter but it has increased by 18% YoY

Dividends

What is ARDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARDX.

Financial health

How did Ardelyx financials performed over time

Assets vs liabilities

ARDX's total assets is 55% greater than its total liabilities
ARDX's total liabilities is up by 38% year-on-year
ARDX's total assets is up by 20% year-on-year but it is down by 6% since the previous quarter

Debt vs equity

Ardelyx's debt is 6% higher than its equity
Ardelyx's debt to equity has surged by 51% YoY and by 19% QoQ
Ardelyx's debt has increased by 48% YoY

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.